Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 24% ± 6% | |
cholangiocyte | 4 studies | 58% ± 26% | |
epithelial cell | 4 studies | 59% ± 18% | |
luminal cell of prostate epithelium | 4 studies | 27% ± 11% | |
GABAergic neuron | 4 studies | 37% ± 12% | |
astrocyte | 4 studies | 35% ± 11% | |
club cell | 4 studies | 24% ± 4% | |
amacrine cell | 3 studies | 20% ± 2% | |
hepatocyte | 3 studies | 46% ± 23% | |
glutamatergic neuron | 3 studies | 54% ± 6% | |
interneuron | 3 studies | 43% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 5994.25 | 235 / 245 | 100% | 53.04 | 502 / 502 |
thymus | 100% | 3226.15 | 651 / 653 | 91% | 12.12 | 551 / 605 |
liver | 100% | 2827.81 | 226 / 226 | 82% | 10.53 | 331 / 406 |
pancreas | 100% | 12683.40 | 328 / 328 | 78% | 8.40 | 139 / 178 |
adrenal gland | 92% | 1007.56 | 238 / 258 | 62% | 3.90 | 142 / 230 |
ovary | 55% | 463.43 | 99 / 180 | 99% | 19.55 | 425 / 430 |
breast | 63% | 2446.10 | 288 / 459 | 87% | 9.56 | 970 / 1118 |
brain | 92% | 1274.70 | 2440 / 2642 | 53% | 2.55 | 371 / 705 |
esophagus | 78% | 1214.73 | 1126 / 1445 | 64% | 5.32 | 118 / 183 |
lung | 54% | 482.61 | 312 / 578 | 59% | 4.54 | 681 / 1155 |
skin | 73% | 3542.31 | 1325 / 1809 | 39% | 2.83 | 184 / 472 |
stomach | 92% | 5639.97 | 331 / 359 | 14% | 1.33 | 41 / 286 |
muscle | 100% | 5191.75 | 803 / 803 | 0% | 0 | 0 / 0 |
uterus | 14% | 236.94 | 23 / 170 | 71% | 8.17 | 328 / 459 |
heart | 82% | 1157.90 | 707 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 5.39 | 29 / 45 |
kidney | 42% | 379.69 | 37 / 89 | 22% | 1.38 | 201 / 901 |
intestine | 45% | 400.60 | 438 / 966 | 12% | 1.25 | 63 / 527 |
spleen | 52% | 390.18 | 125 / 241 | 0% | 0 | 0 / 0 |
bladder | 5% | 26.10 | 1 / 21 | 28% | 1.72 | 141 / 504 |
lymph node | 0% | 0 | 0 / 0 | 21% | 3.76 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 6% | 0.36 | 5 / 80 |
adipose | 4% | 58.23 | 53 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 33.81 | 38 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 31.85 | 44 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007605 | Biological process | sensory perception of sound |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0007216 | Biological process | G protein-coupled glutamate receptor signaling pathway |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_2001256 | Biological process | regulation of store-operated calcium entry |
GO_0048148 | Biological process | behavioral response to cocaine |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043229 | Cellular component | intracellular organelle |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0032426 | Cellular component | stereocilium tip |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0045177 | Cellular component | apical part of cell |
GO_0035256 | Molecular function | G protein-coupled glutamate receptor binding |
GO_0030160 | Molecular function | synaptic receptor adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | HOMER2 |
Protein name | Homer scaffold protein 2 Homer protein homolog 2 (Homer-2) (Cupidin) |
Synonyms | |
Description | FUNCTION: Postsynaptic density scaffolding protein. Binds and cross-links cytoplasmic regions of GRM1, GRM5, ITPR1, DNM3, RYR1, RYR2, SHANK1 and SHANK3. By physically linking GRM1 and GRM5 with ER-associated ITPR1 receptors, it aids the coupling of surface receptors to intracellular calcium release. May also couple GRM1 to PI3 kinase through its interaction with AGAP2. Isoforms can be differently regulated and may play an important role in maintaining the plasticity at glutamatergic synapses . Required for normal hearing . Negatively regulates T cell activation by inhibiting the calcineurin-NFAT pathway. Acts by competing with calcineurin/PPP3CA for NFAT protein binding, hence preventing NFAT activation by PPP3CA . . |
Accessions | Q9NSB8 ENST00000450735.7 [Q9NSB8-2] ENST00000304231.12 [Q9NSB8-1] ENST00000558817.1 H0YNR9 |